Todays announcement Onc announced today upcoming presentation at an annual oncology conference.
they have two posters. One regarding details of anal cancer trail the other? Seems very vague.
my best guess/ understanding is to discuss the biomarker details.
timeliines are interesting in that the presentation posters will not be available until after the Onc, AGM.
Typically the data is under embargo, by the conference rules.
meaning they won't be able to discuss details, other than to say they will be presenting .
100% speculation on my part. Watch for just after the conference , yiu will see Onc advancing the Anal cancer arm to phase 3 approval. Similar to the quick advances we saw with the Pancreatic cancer arm.
that option was hinted at previously.
leaving Onc around mid June with 3 FDA approved phase 3 trials regarding the Gobblet studies with Roche.
That being recommended to advance to phase 3 for MBc, pancreatic & anal cancers.
all that is needed is a business development deal,& final trial details to move forward.